Cargando…

LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma

SIMPLE SUMMARY: Uveal melanoma (UM) is a rare type of intraocular malignancy, which often gives rise to metastases. While treatment with immune checkpoint inhibitors is often effective in the treatment of cutaneous melanoma metastases, it is hardly effective in the case of UM metastases. Lymphocyte-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souri, Zahra, Wierenga, Annemijn P. A., Kroes, Wilma G. M., van der Velden, Pieter A., Verdijk, Robert M., Eikmans, Michael, Luyten, Gregorius P. M., Jager, Martine J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430821/ https://www.ncbi.nlm.nih.gov/pubmed/34503258 http://dx.doi.org/10.3390/cancers13174445

Ejemplares similares

Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2021)

HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2020)

MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3
por: Souri, Zahra, et al.
Publicado: (2021)

Ischemia Is Related to Tumour Genetics in Uveal Melanoma
por: Brouwer, Niels J., et al.
Publicado: (2019)

Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2019)

Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution
por: Brouwer, Niels J., et al.
Publicado: (2019)

Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?
por: van Weeghel, Christiaan, et al.
Publicado: (2019)

In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target
por: ten Voorde, Anna M.W., et al.
Publicado: (2021)

Iris Colour and the Risk of Developing Uveal Melanoma
por: Houtzagers, Laurien E., et al.
Publicado: (2020)

Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma
por: Gelmi, Maria Chiara, et al.
Publicado: (2023)

Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics
por: Wierenga, Annemijn P. A., et al.
Publicado: (2019)

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1
por: Gelmi, Maria Chiara, et al.
Publicado: (2023)

HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target
por: Souri, Zahra, et al.
Publicado: (2019)

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment
por: Gezgin, Gülçin, et al.
Publicado: (2017)

Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma
por: Nell, Rogier J., et al.
Publicado: (2021)

Prognostic Factors Five Years After Enucleation for Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2020)

MR imaging characteristics of uveal melanoma with histopathological validation
por: Ferreira, Teresa A., et al.
Publicado: (2021)

Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma
por: de Lange, Mark J., et al.
Publicado: (2015)

Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma
por: Versluis, Mieke, et al.
Publicado: (2015)

Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2019)

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes
por: van Essen, T. Huibertus, et al.
Publicado: (2016)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment
por: Gezgin, Gülçin, et al.
Publicado: (2022)

Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism
por: de Lange, Mark J., et al.
Publicado: (2015)

The Economic Value of MR-Imaging for Uveal Melanoma
por: Grech Fonk, Lorna, et al.
Publicado: (2020)

Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
por: Yin, Jie, et al.
Publicado: (2023)

Episodic Src activation in uveal melanoma revealed by kinase activity profiling
por: Maat, W, et al.
Publicado: (2009)

Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth
por: el Filali, Mariam, et al.
Publicado: (2008)

Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy
por: Marinkovic, Marina, et al.
Publicado: (2021)

A Comparison of 3 T and 7 T MRI for the Clinical Evaluation of Uveal Melanoma
por: Tang, Michael C.Y., et al.
Publicado: (2021)

High C-Reactive Protein Levels Are Related to Better Survival in Patients with Uveal Melanoma
por: Meijer, Nikki, et al.
Publicado: (2022)

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
por: Cao, Jinfeng, et al.
Publicado: (2016)

EMT-associated factors promote invasive properties of uveal melanoma cells
por: Asnaghi, Laura, et al.
Publicado: (2015)

Bevacizumab and intraocular tumors: an intriguing paradox
por: el Filali, Mariam, et al.
Publicado: (2012)

Magnetic Resonance Imaging in the Clinical Care for Uveal Melanoma Patients—A Systematic Review from an Ophthalmic Perspective
por: Jaarsma-Coes, Myriam G., et al.
Publicado: (2023)

Patients presenting with metastases: stage IV uveal melanoma, an international study
por: Garg, Gaurav, et al.
Publicado: (2022)

Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning
por: Beenakker, Jan-Willem M., et al.
Publicado: (2016)

Inter-Observer Variability in MR-Based Target Volume Delineation of Uveal Melanoma
por: Jaarsma-Coes, Myriam G., et al.
Publicado: (2022)

Spliceosome Mutations in Uveal Melanoma
por: Nguyen, Josephine Q.N., et al.
Publicado: (2020)

Automatic Three-Dimensional Magnetic Resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal melanoma
por: Klaassen, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iq7peq5ukoun240e9c16u32esf